Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea

This study tests a combination of two drugs, ibrutinib and rituximab, in 50 adults with a slow-growing form of mantle cell lymphoma who have not had prior treatment. The main goal is to see how many patients achieve complete remission one year after starting therapy. Researchers …